Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Hypertension Reports
Erschienen in: Current Hypertension Reports 6/2010

01.12.2010

Diagnosis and Treatment of Hypertension in Children

verfasst von: Empar Lurbe, Julio Álvarez, Josep Redon

Erschienen in: Current Hypertension Reports | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Hypertension is a global problem, affecting both developed and developing nations. In children and adolescents, hypertension has gained ground in cardiovascular medicine, thanks to the progress made in several areas of pathophysiologic and clinical research. Childhood hypertension is often asymptomatic and is easily missed, even by health professionals. Target organ damage is detectable in children and adolescents. Management of hypertension includes lifestyle changes and pharmacologic treatment. In the case of secondary hypertension, pharmacologic treatment usually is required. In essential hypertension, assessment of early organ damage provides a useful tool for treatment decisions.
Literatur
1.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004,114(2 Suppl):555–576.
2.
•• Lurbe E, Cifkova R, Cruickshank JK, et al.; European Society of Hypertension: Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 2009, 27:1719–1742. These guidelines represent a consensus among specialists involved in the detection and control of high blood pressure in children and adolescents. The guidelines synthesize a considerable amount of scientific data and clinical experience and represent best clinical wisdom, upon which physicians, nurses, and families should base their decisions. They call attention to the burden of hypertension in children and adolescents and its contribution to the current epidemic of cardiovascular disease. These guidelines should encourage public policy makers to develop a global effort to improve the identification and treatment of high blood pressure among children and adolescents.
3.
Raitakari OT, Juonala M, Kähönen M, et al.: Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003, 290:2277–2283.CrossRefPubMed
4.
Sun SS, Grave GD, Siervogel RM, et al.: Systolic blood pressure in childhood predicts hypertension and metabolic syndrome later in life. Pediatrics 2007, 119:237–246.CrossRefPubMed
5.
• Falkner B, Lurbe E, Schaefer F: High blood pressure in children: clinical and health policy implications. J Clin Hypertens 2010, 12:261–276. This report aims to increase awareness of the problem of hypertension in childhood. Recent reports on prevalence and target organ injury are discussed, and health policy initiatives to improve blood pressure control are proposed.
6.
Menghetti E, Virdis R, Strambi M, et al.: Blood pressure in childhood and adolescence: the Italian normal standards. Study Group on Hypertension of the Italian Society of Pediatrics. J Hypertens 1999, 17:1363–1372.
7.
Park MK, Menard SM, Schoolfield J: Oscillometric blood pressure standards for children. Pediatr Cardiol 2005, 26:601–607.CrossRefPubMed
8.
Jackson LV, Thalange NK, Cole TJ: Blood pressure centiles for Great Britain. Arch Dis Child 2007, 92:298–303.CrossRefPubMed
9.
Harshfield GA, Wilson ME: Ethnic differences in childhood blood pressure. In Pediatric Hypertension. Edited by Portman RJ, Sorof JM, Ingelfinger JR. Totowa, NJ: Humana Press; 2004:293–305.
10.
Sorof JM, Lai D, Turner J, et al.: Overweight, ethnicity and the prevalence of hypertension in school-aged children. Pediatrics 2004, 113:475–482.CrossRefPubMed
11.
National Heart, Lung, and Blood Institute: Report of the Second Task Force on Blood Pressure Control in Children—1987. Pediatrics 1987, 79:1–25.
12.
Sinaiko AR, Gomez-Marin O, Prineas RJ: Prevalence of “significant” hypertension in junior high school-aged children: the Children and Adolescent Blood Pressure Program. J Pediatr 1989, 114:664–669.CrossRefPubMed
13.
Wühl E, Witte K, Soergel M, et al.; German Working Group on Pediatric Hypertension: Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 2002, 20:1995–2007.CrossRefPubMed
14.
Sorof JM, Poffenbarger T, Franco K, Portman R: Evaluation of white-coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Am J Hypertens 2001, 14:855–860.CrossRefPubMed
15.
Pickering TG, Davidson K, Gering W, Schwartz JE: Masked hypertension. Hypertension 2002, 40:795–796.CrossRefPubMed
16.
Mancia G: Reversed white-coat hypertension: definition, mechanisms and prognostic implications. J Hypertens 2002, 20:579–581.CrossRefPubMed
17.
Sorof JM, Portman RJ: White coat hypertension in children with elevated casual blood pressure. J Pediatr 2000, 137:493–497.CrossRefPubMed
18.
Lurbe E, Torro I, Alvarez V, et al.: Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension 2005, 45:493–498.CrossRefPubMed
19.
Stergiou GS, Yiannes NG, Rarra VC, Panagiotakos DB: Home blood pressure normalcy in children and adolescents: the Arsakeion School study. J Hypertens 2007, 25:1375–1379.CrossRefPubMed
20.
Vogt BA: Hypertension in children and adolescents: definition, pathophysiology, risk factors and long-term sequelae. Current Therap Res 2001, 62:283–297.CrossRef
21.
Goonasekera CDA, Dillon MJ: Measurement and interpretation of blood pressure. Arch Dis Child 2000, 82:261–265.CrossRefPubMed
22.
Lurbe E, Redon J: Secondary hypertension in children and adolescents. In Secondary Hypertension. Edited by Mansoor G. Totowa, NJ: Humana Press; 2004:274–304.
23.
Zubrow AB, Hulman S, Kushner H, Falkner B: Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. J Perinatol 1995, 15:470–479.PubMed
24.
Flynn J: Neonatal hypertension: diagnosis and management. Pediatr Nephrol 2000, 14:332–341.CrossRefPubMed
25.
26.
Luma GB, Spiotta RT: Hypertension in children and adolescents. Am Fam Physician 2006, 73:1558–1568.PubMed
27.
28.
Swinford RD, Portman RJ: Diagnostic evaluation of pediatric hypertension. In Pediatric Hypertension. Edited by Portman RJ, Sorof JM, Ingelfinger JR. Totowa, NJ: Humana Press; 2004:405–420.
29.
Brewer ED: Evaluation of hypertension in childhood diseases. In Pediatric Nephrology. Edited by Avner ED, Harmon WE, Niaudet P. Philadelphia: Lippincott Williams & Wilkins; 2004:1179–1197.
30.
Devereux RB, Alonso DR, Lutas EM, et al.: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57:450–458.CrossRefPubMed
31.
de Simone G, Devereux RB, Daniels SR, et al.: Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995, 25:1056–1062.CrossRefPubMed
32.
Daniels SR, Kimball TR, Morrison JA, et al.: Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol 1995, 76:699–701.CrossRefPubMed
33.
Hanevold C, Waller J, Daniels S, et al.; International Pediatric Hypertension Association: The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics 2004, 113:328–333.CrossRefPubMed
34.
Litwin M, Niemirska A, Sladowska J, et al.: Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol 2006, 21:811–819.CrossRefPubMed
35.
McNiece KL, Gurpa-Malhotra M, Samuels J, et al.; National High Blood Pressure Education Program Working Group: Left ventricular hypertrophy in hypertensive adolescents. Analysis of risk by 2004 National High Blood Pressure Education Program Working Group staging criteria. Hypertension 2007, 50:392–395.
36.
Sorof JM, Alexandrov AV, Garami Z, et al.: Carotid ultrasonography for detection of vascular abnormalities in hypertensive children. Pediatr Nephrol 2003, 18:1020–1024.CrossRefPubMed
37.
Zhu W, Huang X, He J, et al.: Arterial intima-media thickening and endothelial dysfunction in obese Chinese children. Eur J Pediatr 2005, 164:337–344.CrossRefPubMed
38.
Jourdan C, Wühl E, Litwin M, et al.: Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 2005, 23:1707–1715.CrossRefPubMed
39.
Sinha MD, Reid CJ: Evaluation of blood pressure in children. Curr Opin Nephrol Hypertens 2007, 16:577–584.CrossRefPubMed
40.
Assadi F: Relation of left ventricular hypertrophy to microalbuminuria and C-reactive protein in children and adolescents with essential hypertension. Pediatr Cardiol 2008, 29:580–584.CrossRefPubMed
41.
Torrance B, McGuire KA, Lewanczuk R, McGavock J: Overweight, physical activity and high blood pressure in children: a review of the literature. Vasc Health Risk Manag 2007, 3:139–149.PubMed
42.
Salminen M, Vahlberg T, Kivela SL: Effects of family-oriented risk-based prevention on serum cholesterol and blood pressure values of children and adolescents. Scand J Prim Health Care 2005, 23:34–41.CrossRefPubMed
43.
Addison CC, Jenkins BW, White MS, Young L: Implementation of a cardiovascular disease prevention program among school-aged children: a pilot study. Int J Environ Res Public Health 2006, 3:274–277.CrossRefPubMed
44.
Hayman LL, Meininger JC, Daniels SR, et al.: Primary prevention of cardiovascular disease in nursing practice: focus on children and youth: a scientific statement from the American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in Youth of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2007, 116:344–357.CrossRefPubMed
45.
Regulation (EC) No. 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No. 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. Official Journal of the European Union 27/12/2006.
46.
• Simonetti G, Rizzi M, Donadini R, Bianchetti MG: Effects of antihypertensive drugs on blood pressure and proteinuria in childhood. J Hypertens 2007, 25:2370–2376. The blood pressure reduction of ACE inhibitors, ARBs, and calcium-channel blockers is almost identical. In children with pathologic proteinuria, ACE inhibitors or ARBs are superior to calcium-channel blockers.
47.
• Kupferman JC, Paterno K, Mahgerefteh J, et al.: Improvement of left ventricular mass with antihypertensive therapy in children with hypertension. Pediatr Nephrol 2010, 25:1513–1518. This study demonstrates that LVH in hypertensive children improves with effective blood pressure control.
48.
•• ESCAPE Trial Group, Wühl E, Trivelli A, et al.: Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009, 361:1639–1650. Intensified blood pressure control, with target 24-hour blood pressure levels in the low range of normal, confers a substantial benefit with respect to renal function among children with chronic kidney disease. Reappearance of proteinuria after initial successful pharmacologic blood pressure control is common among children who are receiving long-term ACE inhibition.
Metadaten
Titel
Diagnosis and Treatment of Hypertension in Children
verfasst von
Empar Lurbe
Julio Álvarez
Josep Redon
Publikationsdatum
01.12.2010
Verlag
Current Science Inc.
Erschienen in
Current Hypertension Reports / Ausgabe 6/2010
Print ISSN: 1522-6417
Elektronische ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-010-0155-x

Weitere Artikel der Ausgabe 6/2010

Current Hypertension Reports 6/2010 Zur Ausgabe

ReviewPaper

Cytostatic Drugs, Neuregulin Activation of ErbB Receptors, and Angiogenesis

ReviewPaper

Vascular Endothelial Function and Hypertension: Insights and Directions

ReviewPaper

Mitochondrial Dysfunction and Oxidative Damage to Sarcomeric Proteins

Literature Alert

Hemoconcentration, Heart Failure, and Survival

ReviewPaper

Establishing Targets for Hypertension Control in Patients with Comorbidities

Clinical Trial Report

Insulin Sensitizers and Heart Failure: An Engine Flooded with Fuel

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Ist Fasten vor Koronarinterventionen wirklich nötig?

04.06.2024 Interventionelle Verfahren in der Kardiologie Nachrichten

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise